Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pediatrix Medical (MD) Change in Accured Expenses (2016 - 2025)

Pediatrix Medical (MD) has disclosed Change in Accured Expenses for 17 consecutive years, with -$13.4 million as the latest value for Q4 2025.

  • On a quarterly basis, Change in Accured Expenses fell 217.26% to -$13.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$26.1 million, a 14.93% decrease, with the full-year FY2025 number at -$26.1 million, down 14.93% from a year prior.
  • Change in Accured Expenses was -$13.4 million for Q4 2025 at Pediatrix Medical, down from -$3.3 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $158.4 million in Q2 2022 to a low of -$159.7 million in Q1 2025.
  • A 5-year average of -$3.0 million and a median of -$6.4 million in 2022 define the central range for Change in Accured Expenses.
  • Peak YoY movement for Change in Accured Expenses: tumbled 546.92% in 2022, then soared 955.91% in 2023.
  • Pediatrix Medical's Change in Accured Expenses stood at $26.6 million in 2021, then plummeted by 136.37% to -$9.7 million in 2022, then skyrocketed by 147.25% to $4.6 million in 2023, then surged by 150.49% to $11.5 million in 2024, then tumbled by 217.26% to -$13.4 million in 2025.
  • Per Business Quant, the three most recent readings for MD's Change in Accured Expenses are -$13.4 million (Q4 2025), -$3.3 million (Q3 2025), and $150.4 million (Q2 2025).